VeriChip expands hospital infrastructure with VeriChip system for patient identification

Delray Beach 22 August 2005Trinitas Hospital, a health care facility based in Elizabeth, New Jersey has agreed to implement the VeriMed microchip system and will initiate a clinical evaluation programme of the system in its two Emergency Departments for rapid patient identification purposes. Upon implementation, each facility will be able to scan patients to obtain their VeriChip ID Number and utilize the associated database information. During the month of July, three additional hospitals in the Boston to Washington corridor have agreed to adopt the VeriChip system for patient identification. Overall, since the FDA clearance of VeriChip for medical applications, five hospitals have agreed to adopt the VeriChip system in their emergency departments.


Trinitas becomes the sixth hospital that has agreed to adopt the VeriMed System in their emergency department in the last five months and the third hospital in the State of New Jersey to employ the VeriMed System. Previously, Hackensack University Medical Center and another large hospital network in New Jersey selected the system for use in its emergency room.

Commenting on Trinitas Hospital's decision to enable its Emergency Department physicians and staff to utilize the VeriChip System, Kevin McLaughlin, CEO of VeriChip Corporation commented: "We are pleased that Trinitas Hospital, a progressive and well respected medical centre, recognizes that the VeriChip technology can enhance clinical and emergency care and expand the use of its patient information system across all clinical services. Area physicians will soon be able to recommend a VeriMed microchip to patients knowing that Trinitas Hospital has the capacity of both reading the microchip and accessing electronically stored medical information. Together with Trinitas, we anticipate the result will be more rapid and accurate access to crucial medical information when patient communication is diminished or absent. By attracting three of the leading hospitals in the northern New Jersey area, we have taken important steps to gain traction in the New York Metropolitan area, which represents millions of potential patients for VeriChip."

Gary Horan, President of Trinitas Hospital, stated: "We look forward to utilizing the VeriMed system to assist in patient identification and access to medical information. Particularly beneficial for patients with chronic illnesses, this modality will assist us in expediting the quality level of care which we provide."

Established in January 2000, following the consolidation of St. Elizabeth Hospital and Elizabeth General Medical Center, Trinitas Hospital is a full-service health care facility serving those who live and work in Eastern and Central Union County. Operating on two major campuses, Trinitas Hospital has 531 beds, including a 120-bed long-term care centre. Trinitas Hospital is proud to offer state-of-the-art medicine backed by compassion and competence.

VeriChip Corporation previously announced its goal of having 20 to 25 hospitals to agree to adopt the VeriChip system by the end of 2005. The company has targeted the Boston to Washington corridor as the initial roll-out region for VeriChip system infrastructure.

The company plans to provide monthly updates on the total number of hospitals that have agreed to adopt the VeriChip system. These hospitals will be named when the system is fully implemented and functional in the hospitals' emergency rooms. The company is taking this approach in order to allow for an orderly system implementation process, which normally requires a number of weeks. This process includes initial clinical discussions with hospital staff, on-site demonstrations, provision of starter kits, and detailed staff training.

VeriChip Corporation Chief Executive Officer Kevin McLaughlin noted: "There are currently 70 hospitals in the Boston to Washington corridor that are using VeriChip Corporation's Hugs and Halo external RFID technology in their maternity wards. The emergency departments of those hospitals are among those being targeted by our VeriChip sales force as we continue the initial roll-out of VeriChip patient identification infrastructure."

VeriChip is a subsidiary of Applied Digital and the only company to provide both implantable and wearable RFID identification and security solutions for people, their assets, and their environments. From the world's first and only FDA-cleared, human-implantable RFID microchip to the only patented active RFID tag with skin-sensing capabilities, VeriChip leads the way in next-generation RFID technologies. Today, over 3000 installations worldwide in health care, security, industrial, and government markets benefit from both the protection and efficiencies provided by VeriChip systems.

Applied Digital develops innovative identification and security products for consumer, commercial, and government sectors worldwide. The company's unique and often proprietary products provide identification and security systems for people, animals, the food supply, government/military arena, and commercial assets. Included in this diversified product line are RFID applications, end-to-end food safety systems, GPS/Satellite communications, and telecomm and security infrastructure, positioning Applied Digital as an expert in identification technology. Applied Digital is the owner of a majority position in Digital Angel Corporation.

More news on VeriChip is available in the VMW June 2005 article Applied Digital's VeriChip Corporation introduces improved patient wander protection.

Leslie Versweyveld

[Medical IT News][Calendar][Virtual Medical Worlds Community][News on Advanced IT]